<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd"><html xmlns="http://www.w3.org/1999/xhtml"><head><title>R: Vaccine study Data</title>
<meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
<link rel="stylesheet" type="text/css" href="R.css" />
</head><body>

<table width="100%" summary="page for vac18 {mixOmics}"><tr><td>vac18 {mixOmics}</td><td style="text-align: right;">R Documentation</td></tr></table>

<h2>Vaccine study Data</h2>

<h3>Description</h3>

<p>The data come from a trial evaluating a vaccine based on HIV-1 lipopeptides in HIV-negative volunteers. The vaccine (HIV-1 LIPO-5 ANRS vaccine) contains five HIV-1 amino acid sequences coding for Gag, Pol and Nef proteins.
This data set contains the expression measure of a subset of 1000 genes from purified in vitro stimulated Peripheral Blood Mononuclear Cells from 42 repeated samples (12 unique vaccinated participants) 14 weeks after vaccination, , 6 hours after in vitro stimulation by either (1) all the peptides included in the vaccine (LIPO-5), or (2) the Gag peptides included in the vaccine (GAG+) or (3) the Gag peptides not included in the vaccine (GAG-) or (4) without any stimulation (NS).
</p>


<h3>Usage</h3>

<pre>data(vac18)</pre>


<h3>Format</h3>

<p>A list containing the following components:
</p>

<dl>
<dt><code>gene</code></dt><dd><p>data frame with 42 rows and 1000 columns.
The expression measure of 1000 genes for the 42 samples (PBMC cells from 12 unique subjects).</p>
</dd>
<dt><code>stimulation</code></dt><dd><p>is a fctor of 42 elements indicating the type of in vitro simulation for each sample.</p>
</dd>
<dt><code>sample</code></dt><dd><p>is a vector of 42 elements indicating the unique subjects (for example the value '1' correspond to the first patient PBMC cells). Note that the design of this study is unbalanced.</p>
</dd>
<dt><code>tab.prob.gene</code></dt><dd><p>is a data frame with 1000 rows and 2 columns, indicating the Illumina probe ID and the gene name of the annotated genes.</p>
</dd>
</dl>



<h3>Details</h3>

<p>This is a subset of the original study for illustrative purposes.
</p>


<h3>Value</h3>

<p>none</p>


<h3>References</h3>

<p>Salmon-Ceron D, Durier C, Desaint C, Cuzin L, Surenaud M, Hamouda N, Lelievre J, Bonnet B, Pialoux G, Poizot-Martin I, Aboulker J, Levy Y, Launay O, trial group AV: Immunogenicity and safety of an HIV-1 lipopeptide vaccine in healthy adults: a phase 2 placebo-controlled ANRS trial. AIDS 2010, 24(14):2211-2223.
</p>

<hr /><div style="text-align: center;">[Package <em>mixOmics</em> version 6.6.2 <a href="00Index.html">Index</a>]</div>
</body></html>
